Questionnaire for Developing the Korean Medication Algorithm for the Treatment of Schizophrenia.
- Author:
Yong Min AHN
1
;
Jun Soo KWON
;
Dae Yeob KANG
;
Seung Hyun KIM
;
Chang Yoon KIM
;
Won Myong BAHK
;
Joo Cheol SHIM
;
Suk Kyoon AN
;
Jung Seo YI
;
Hyun Sang CHO
;
Hong Shick LEE
;
Yong Sik KIM
Author Information
1. Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
KMAP;
Schizophrenia;
Pharmacotherapy;
Algorithm
- MeSH:
Advisory Committees;
Antipsychotic Agents;
Committee Membership;
Drug Therapy;
Hospitals, Psychiatric;
Psychiatry;
Surveys and Questionnaires*;
Schizophrenia*
- From:Korean Journal of Psychopharmacology
2004;15(2):219-235
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
KMAP (Korean Medication Algorithm Project for Major Psychiatric Disorders) was established to develop Korean algorithm for major psychiatric disorders. KMAP developed the draft of Korean medication algorithm for schizophrenia and assessed the level of satisfaction and fitness in the Review Committee using questionnaire about this draft. The members of Review Committee were medical doctors of psychiatry who were interested in the research of psychiatric drugs or were experienced in psychiatric pharmacotherapy in college of medicine, mental hospital or private psychiatric clinic. 57 psychiatrists were appointed as committee of re-examination of algorithm and 48 (84.2%) answered the questionnaire. The Korean medication algorithm draft for schizophrenia was based upon Korean clinical research, clinical experience of Korean professionals and clinical guidelines of other countries. The draft of this algorithm was categorized into 32 items, then we made a questionnaire according to these items. The answers of each question were consist of 5 levels of satisfaction, and the committee members could propose free opinion about these questions. The results of questionnaire were presented and discussed in an open forum. In most items except two, over half of committee members answered that `correction unnecessary of draft'. The 2 items showing low level of satisfaction were `trial of atypical antipsychotics at level 1', `trial of typical antipsychotics at level 4'. These items were revised from the draft after having discussion in an open forum. And then we published the first edition of `Korean Medication Algorithm for Schizophrenia'.
